(19)
(11) EP 0 536 213 A1

(12)

(43) Date of publication:
14.04.1993 Bulletin 1993/15

(21) Application number: 91911788.0

(22) Date of filing: 28.06.1991
(51) International Patent Classification (IPC): 
A01K 67/ 027( . )
C07K 14/ 47( . )
C12N 5/ 10( . )
C12N 15/ 12( . )
C12P 21/ 02( . )
A61K 38/ 00( . )
C07K 14/ 00( . )
C07K 16/ 00( . )
C12N 15/ 09( . )
C12N 15/ 85( . )
C12Q 1/ 68( . )
C12R 1/ 91( . )
(86) International application number:
PCT/GB1991/001057
(87) International publication number:
WO 1992/000375 (09.01.1992 Gazette 1992/02)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IT LI LU NL SE

(30) Priority: 28.06.1990 GB 19900014446
13.07.1990 GB 19900015488
09.05.1991 GB 19910010085

(71) Applicant: IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED
London WC2A 3NL (GB)

(72) Inventors:
  • GOODFELLOW, Peter, Neville
    London WC2A 3PX (GB)
  • LOVELL-BADGE, Robin Medical Research Council
    Mill Hill London NW7 1AD (GB)

(74) Representative: Cresswell, Thomas Anthony, et al 
J.A. KEMP & CO. 14 South Square Gray's Inn
London WC1R 5LX
London WC1R 5LX (GB)

   


(54) SEXE DETERMINING GENE